Advanced Genotypic and Phenotypic monitoring of Drug Resistant TB to Improve TB Treatment Outcomes
- Institution
- ALBERT EINSTEIN COLLEGE OF MEDICINE, NY
- Principal investigator
- Michelle H Larsen
- Funding
- $846K
- Duration
- 2015–2030
Moonbase score
Still being scored
Abstract
Modified Project Summary/Abstract Section This project utilizes translational approaches to use novel assays to understand the emergence of resistance to drugs to treat Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). Drug-resistant TB incidence has increased 80% worldwide over the past 15 years with high mortality, prolonged treatment course, and poor outcomes. Global multi-drug resistant TB (MDR-TB) cure rates average 65% and as many as 11% of MDR-TB patients develop amplification of drug-resistance on treatment. While emergent drug- resistance is a major challenge it is often detected too late. This application will study Mtb clinical isolates from patients with extensive clinical and adherence data. Transcriptomics, metabolomics, and respiratory capacity will be measured in these clinical Mtb isolates. Functional assays for detecting drug-resistance will be done to better understand development of drug-resistance under treatment.
Research team
- Michelle H LarsenPI
- Kogieleum NaidooPI
- Threnesan NaidooPI
- Max O'DonnellPI
- Adrie Jc SteynPI
LOADING MOONBASE SCORE
Questions for ALBERT EINSTEIN COLLEGE OF MEDICINE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Rutgers Biomedical and Health SciencesNot yet scored
B cells in the regulation of lung granulomatous inflammation in TB
John R. Chan · $781K · 2025–2030
- NIH · Columbia University Health SciencesNot yet scored
Targeting TB transmission hotspots to find undiagnosed TB in South Africa: a genomic, geospatial and modeling study (TARGET- TB)
Barun Mathema · $314K · 2025–2026
- NIH · Columbia University Health SciencesNot yet scored
Targeting TB transmission hotspots to find undiagnosed TB in South Africa: a genomic, geospatial and modeling study (TARGET- TB)
Barun Mathema · $380K · 2021–2026